| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
41,639 |
37,533 |
$3.70M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,012 |
12,949 |
$1.76M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
9,150 |
8,821 |
$990K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
7,627 |
7,390 |
$905K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,896 |
7,566 |
$850K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,372 |
5,648 |
$635K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
10,692 |
9,983 |
$463K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,686 |
6,235 |
$357K |
| 90686 |
|
11,196 |
10,827 |
$254K |
| 92551 |
|
23,103 |
22,354 |
$219K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
4,620 |
4,417 |
$160K |
| 99381 |
|
1,325 |
1,219 |
$141K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12,989 |
6,658 |
$136K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
999 |
898 |
$110K |
| 90648 |
|
4,109 |
3,907 |
$92K |
| 99177 |
|
15,568 |
15,036 |
$78K |
| 90670 |
|
3,192 |
3,041 |
$72K |
| 96161 |
|
26,524 |
25,178 |
$68K |
| 90723 |
|
2,940 |
2,809 |
$66K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,142 |
4,855 |
$65K |
| 90651 |
|
2,834 |
2,715 |
$65K |
| D1206 |
Topical application of fluoride varnish |
2,605 |
2,551 |
$64K |
| 99383 |
|
510 |
485 |
$61K |
| 90680 |
|
2,636 |
2,515 |
$59K |
| 96127 |
|
12,487 |
12,012 |
$58K |
| 90633 |
|
2,582 |
2,469 |
$58K |
| 99173 |
|
17,002 |
16,366 |
$41K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,787 |
1,616 |
$40K |
| 90620 |
|
1,466 |
1,377 |
$39K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,864 |
3,711 |
$34K |
| 96160 |
|
11,884 |
11,299 |
$33K |
| 99070 |
|
4,401 |
4,183 |
$32K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,137 |
2,833 |
$29K |
| 0071A |
|
737 |
698 |
$28K |
| 90734 |
|
1,191 |
1,147 |
$27K |
| 90715 |
|
1,182 |
1,103 |
$27K |
| 99384 |
|
204 |
198 |
$27K |
| 90656 |
|
1,091 |
1,088 |
$25K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,475 |
1,373 |
$24K |
| 90716 |
|
1,068 |
1,019 |
$24K |
| 0072A |
|
600 |
589 |
$24K |
| 99051 |
|
2,308 |
2,118 |
$24K |
| 90710 |
|
1,027 |
973 |
$23K |
| 90707 |
|
1,009 |
970 |
$23K |
| 90700 |
|
998 |
952 |
$23K |
| 92587 |
|
1,006 |
963 |
$21K |
| 90677 |
|
926 |
882 |
$21K |
| 90696 |
|
891 |
847 |
$20K |
| 90619 |
|
961 |
857 |
$20K |
| 99382 |
|
166 |
158 |
$19K |
| 87807 |
|
1,627 |
1,471 |
$17K |
| 0002A |
|
448 |
436 |
$17K |
| 0001A |
|
445 |
441 |
$16K |
| 99401 |
|
2,583 |
2,295 |
$15K |
| 99050 |
|
957 |
798 |
$11K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
95 |
93 |
$10K |
| 99215 |
Prolong outpt/office vis |
57 |
57 |
$10K |
| 0003A |
|
159 |
141 |
$6K |
| 85018 |
|
3,350 |
3,151 |
$6K |
| 86403 |
|
665 |
640 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
29 |
27 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
327 |
255 |
$4K |
| 90480 |
|
109 |
100 |
$4K |
| 94010 |
|
141 |
126 |
$4K |
| 90661 |
|
246 |
205 |
$4K |
| 87400 |
|
298 |
171 |
$3K |
| 94760 |
|
3,220 |
2,708 |
$3K |
| 81002 |
|
1,165 |
1,059 |
$3K |
| 0124A |
|
66 |
63 |
$3K |
| 90381 |
|
47 |
47 |
$2K |
| 90688 |
|
117 |
107 |
$2K |
| A7016 |
Dome and mouthpiece, used with small volume ultrasonic nebulizer |
311 |
270 |
$2K |
| 84030 |
|
732 |
665 |
$1K |
| 0154A |
|
37 |
33 |
$1K |
| 81025 |
|
182 |
177 |
$1K |
| 90380 |
|
24 |
24 |
$942.32 |
| 91320 |
|
37 |
33 |
$876.06 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
59 |
55 |
$825.74 |
| 0081A |
|
22 |
13 |
$800.00 |
| 90744 |
|
34 |
34 |
$791.52 |
| 36416 |
|
2,944 |
2,300 |
$691.00 |
| 0074A |
|
21 |
13 |
$640.00 |
| 99001 |
|
1,777 |
1,602 |
$360.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
15 |
15 |
$329.56 |
| 92567 |
|
14 |
13 |
$261.49 |
| 90687 |
|
12 |
12 |
$256.08 |
| 96380 |
|
27 |
27 |
$229.08 |
| 99072 |
|
1,427 |
1,289 |
$168.00 |
| 90658 |
|
12 |
12 |
$164.16 |
| 96381 |
|
36 |
36 |
$133.04 |
| 36415 |
Collection of venous blood by venipuncture |
26 |
25 |
$39.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
302 |
257 |
$18.23 |
| S3620 |
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
13 |
12 |
$9.00 |
| 91300 |
|
307 |
267 |
$0.13 |
| 91315 |
|
31 |
28 |
$0.11 |
| 91307 |
|
332 |
285 |
$0.01 |
| 91312 |
|
15 |
15 |
$0.01 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
4,490 |
4,307 |
$0.00 |
| G9920 |
Screening performed and negative |
2,058 |
1,963 |
$0.00 |
| G9919 |
Screening performed and positive and provision of recommendations |
718 |
674 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
43 |
40 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
75 |
74 |
$0.00 |
| 90461 |
|
12 |
12 |
$0.00 |